Tags

Type your tag names separated by a space and hit enter

Update on universal childhood immunizations.
Curr Opin Pediatr. 2008 Aug; 20(4):483-9.CO

Abstract

PURPOSE OF REVIEW

To provide an update of research findings and recommendations regarding immunizations.

RECENT FINDINGS

New research has examined the efficacy of the 2007-2008 influenza vaccine, the transmission and incidence of human papillomavirus, the increased prevalence of pneumococcal serotypes not included in the 7-valent pneumococcal conjugate vaccine, the emergence of a drug-resistant strain of Streptococcus pneumoniae, febrile seizure rates following measles-mumps-rubella-varicella vaccination, and the 2006 mumps outbreak in the American Midwest. The Food and Drug Administration has approved the expansion of live attenuated influenza virus vaccine and quadrivalent meningococcal conjugate vaccine for use in children no younger than 2 years of age. The Advisory Committee on Immunization Practices now recommends immunization with quadrivalent meningococcal conjugate vaccine for all previously unvaccinated 11-18-year-old children and has revised its recommendations for Streptococcus pneumoniae catch-up vaccinations. The Advisory Committee on Immunization Practices no longer expresses a preference for the use of the combination measles-mumps-rubella-varicella vaccine over separate measles-mumps-rubella and varicella administration. Because of a notable recall of Haemophilus influenzae type B vaccines by Merck & Co Inc, Whitehouse Station, New Jersey, USA, the Advisory Committee on Immunization Practices recommends that pediatric providers conserve available Haemophilus influenzae type B vaccines by delaying the administration of the booster dose of the vaccine in healthy children.

SUMMARY

New vaccine recommendations continue to be made, and research continues on infectious diseases, vaccine safety, and vaccine efficacy.

Authors+Show Affiliations

Department of Pediatrics, Dartmouth Medical School, General Academic Pediatrics, Children's Hospital at Dartmouth, Lebanon, New Hampshire 03756, USA.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18622208

Citation

Hamlin, Jean, et al. "Update On Universal Childhood Immunizations." Current Opinion in Pediatrics, vol. 20, no. 4, 2008, pp. 483-9.
Hamlin J, Senthilnathan S, Bernstein HH. Update on universal childhood immunizations. Curr Opin Pediatr. 2008;20(4):483-9.
Hamlin, J., Senthilnathan, S., & Bernstein, H. H. (2008). Update on universal childhood immunizations. Current Opinion in Pediatrics, 20(4), 483-9. https://doi.org/10.1097/MOP.0b013e328306ebd1
Hamlin J, Senthilnathan S, Bernstein HH. Update On Universal Childhood Immunizations. Curr Opin Pediatr. 2008;20(4):483-9. PubMed PMID: 18622208.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update on universal childhood immunizations. AU - Hamlin,Jean, AU - Senthilnathan,Selvi, AU - Bernstein,Henry H, PY - 2008/7/16/pubmed PY - 2008/9/27/medline PY - 2008/7/16/entrez SP - 483 EP - 9 JF - Current opinion in pediatrics JO - Curr Opin Pediatr VL - 20 IS - 4 N2 - PURPOSE OF REVIEW: To provide an update of research findings and recommendations regarding immunizations. RECENT FINDINGS: New research has examined the efficacy of the 2007-2008 influenza vaccine, the transmission and incidence of human papillomavirus, the increased prevalence of pneumococcal serotypes not included in the 7-valent pneumococcal conjugate vaccine, the emergence of a drug-resistant strain of Streptococcus pneumoniae, febrile seizure rates following measles-mumps-rubella-varicella vaccination, and the 2006 mumps outbreak in the American Midwest. The Food and Drug Administration has approved the expansion of live attenuated influenza virus vaccine and quadrivalent meningococcal conjugate vaccine for use in children no younger than 2 years of age. The Advisory Committee on Immunization Practices now recommends immunization with quadrivalent meningococcal conjugate vaccine for all previously unvaccinated 11-18-year-old children and has revised its recommendations for Streptococcus pneumoniae catch-up vaccinations. The Advisory Committee on Immunization Practices no longer expresses a preference for the use of the combination measles-mumps-rubella-varicella vaccine over separate measles-mumps-rubella and varicella administration. Because of a notable recall of Haemophilus influenzae type B vaccines by Merck & Co Inc, Whitehouse Station, New Jersey, USA, the Advisory Committee on Immunization Practices recommends that pediatric providers conserve available Haemophilus influenzae type B vaccines by delaying the administration of the booster dose of the vaccine in healthy children. SUMMARY: New vaccine recommendations continue to be made, and research continues on infectious diseases, vaccine safety, and vaccine efficacy. SN - 1531-698X UR - https://www.unboundmedicine.com/medline/citation/18622208/Update_on_universal_childhood_immunizations_ L2 - https://doi.org/10.1097/MOP.0b013e328306ebd1 DB - PRIME DP - Unbound Medicine ER -